Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 71 clinical trials
Featured trial
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

  • 88 views
  • 08 Nov, 2020
  • 1 location
Digoxin Short Term Treatment Assessment Randomized Trial in AHF (DIG-STA-AHF)

> Whether digoxin is efficient and safe in short term treatment of acute heart failure is a question that should be studied.

  • 5 views
  • 23 Feb, 2022
  • 2 locations
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia (InSaKa)

Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease, diabetes mellitus, or heart failure. Globally, the reported incidence of hyperkalemia varies from 1.1 to 10 per 100 hospitalizations, depending on the patient cohort and comorbidities. Hyperkalemia is a potentially life-threatening electrolyte disturbance that can be fatal …

  • 1 views
  • 26 Mar, 2022
  • 4 locations
Ertugliflozin in Acute Heart Failure

The purpose of this study is to determine the effects on heart failure signs and symptoms of the use of either ertugliflozin, metolazone or placebo, in conjunction with intravenous loop diuretic use in acute settings and chronic oral loop diuretic therapy. There are two general purposes for this study. The …

  • 0 views
  • 20 May, 2021
  • 1 location
Acute Heart Failure - COngestion Discharge Evaluation (AHF-CODE)

Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of death or re-hospitalisation at 3 months. This risk is significantly increased by insufficient

pulmonary congestion
natriuretic peptide
congestion
  • 0 views
  • 23 Mar, 2022
  • 1 location
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

> The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk

  • 0 views
  • 30 Jan, 2021
  • 1 location
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation

. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are

  • 12 views
  • 02 Feb, 2021
  • 1 location
A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction

The purpose of this study is to evaluate the safety, pharmacokinetics, and effect on cardiac function of intravenous APD418 in adult participants with heart failure with reduced ejection fraction (HFrEF).

  • 0 views
  • 12 Mar, 2022
  • 2 locations
Evaluation of a Non-invasive Urinary Collection Technique for the Adaptation of Diuretic Treatment in Incontinent Heart Failure Patient Over 75 Years of Age in the Acute Phase (ATIICA)

generates a significant cost for our health system. The management of patients over 75 years of age in acute heart failure requires special monitoring of diuresis and weight. However, it is sometimes

  • 0 views
  • 05 May, 2022
  • 1 location
Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic Shock

Background Cardiogenic shock is a life-threatening state of acute heart failure with severely depressed blood pressure and organ perfusion. The 30-day mortality is reported as high as 50%. To

  • 0 views
  • 27 Jan, 2021
  • 1 location